Papas Rebecca K, Gakinya Benson N, Mwaniki Michael M, Keter Alfred K, Lee Hana, Loxley Michelle P, Klein Debra A, Sidle John E, Martino Steve, Baliddawa Joyce B, Schlaudt Kathryn L, Maisto Stephen A
Alpert Medical School of Brown University, Providence, Rhode Island.
School of Medicine, Moi University College of Health Sciences, Eldoret, Kenya.
Alcohol Clin Exp Res. 2016 Aug;40(8):1779-87. doi: 10.1111/acer.13132. Epub 2016 Jul 18.
To counteract the syndemics of HIV and alcohol in Sub-Saharan Africa, international collaborations have developed interventions to reduce alcohol consumption. Reliable and accurate methods are needed to estimate alcohol use outcomes. A direct alcohol biomarker called phosphatidylethanol (PEth) has been shown to validate heavy, daily drinking, but the literature indicates mixed results for moderate and nondaily drinkers, including among HIV-infected populations. This study examined the associations of the PEth biomarker with self-report alcohol use at 2 time points in 127 HIV-infected outpatient drinkers in western Kenya.
Participants were consecutively enrolled in a randomized clinical trial to test the efficacy of a behavioral intervention to reduce alcohol use in Eldoret, Kenya. They endorsed current alcohol use, and a minimum score of 3 on the Alcohol Use Disorders Identification Test-Consumption or consuming ≥6 drinks per occasion at least monthly in the past year. Study interviews and blood draws were conducted at baseline and at 3 months post treatment from July 2012 through September 2013. Alcohol use was assessed using the Timeline Followback questionnaire. Blood samples were analyzed for the presence of the PEth biomarker and were compared to self-reported alcohol use. We also conducted semistructured interviews with 14 study completers in February through March 2014.
Baseline data indicated an average of moderate-heavy alcohol use: 50% drinking days and a median of 4.5 drinks per drinking day. At baseline, 46% of women (31 of 67) and 8% of men (5 of 60) tested negative for PEth (p < 0.001). At the 3-month follow-up, 93% of women (25 of 27) and 97% of men (30 of 31) who reported drinking tested positive, while 70% of women (28 of 40) and 35% of men (10 of 29) who denied drinking tested negative for PEth. Interviews were consistent with self-reported alcohol use among 13 individuals with negative baseline results.
These results add to the growing literature showing lack of agreement between self-report and PEth results among unhealthy and nondaily drinkers, particularly women. More research is needed to determine at what level of consumption over what period of time PEth becomes a reliable and accurate indicator of alcohol use.
为应对撒哈拉以南非洲地区艾滋病毒和酒精的并发问题,国际合作开展了旨在减少酒精消费的干预措施。需要可靠且准确的方法来评估酒精使用结果。一种名为磷脂酰乙醇(PEth)的直接酒精生物标志物已被证明可验证重度每日饮酒情况,但文献表明,对于中度饮酒者和非每日饮酒者,包括艾滋病毒感染人群,结果不一。本研究在肯尼亚西部127名感染艾滋病毒的门诊饮酒者中,于两个时间点检验了PEth生物标志物与自我报告的酒精使用之间的关联。
参与者连续纳入一项随机临床试验,以测试在肯尼亚埃尔多雷特进行的一项减少酒精使用行为干预的疗效。他们认可当前饮酒情况,且在酒精使用障碍识别测试-消费项目中得分至少为3分,或在过去一年中每月至少有一次每次饮用≥6杯酒。2012年7月至2013年9月期间,在基线和治疗后3个月进行研究访谈和采血。使用时间线追溯问卷评估酒精使用情况。对血样进行PEth生物标志物检测,并与自我报告的酒精使用情况进行比较。2014年2月至3月,我们还对14名研究完成者进行了半结构化访谈。
基线数据表明平均为中度至重度酒精使用:饮酒天数占50%,每次饮酒日的饮酒量中位数为4.5杯。在基线时,46%的女性(67名中的31名)和8%的男性(60名中的5名)PEth检测呈阴性(p<0.001)。在3个月随访时,报告饮酒的93%的女性(27名中的25名)和97%的男性(31名中的30名)检测呈阳性,而否认饮酒的70%的女性(40名中的28名)和35%的男性(29名中的10名)PEth检测呈阴性。访谈结果与13名基线结果为阴性的个体自我报告的酒精使用情况一致。
这些结果进一步证明,在不健康和非每日饮酒者,尤其是女性中,自我报告与PEth结果之间存在不一致,这一现象在不断增加的文献中有所体现。需要更多研究来确定在何种饮酒水平和时间段内,PEth能成为可靠且准确的酒精使用指标。